NEW YORK - (Business Wire) The NanoBusiness Alliance today announced that Vice President Vincent Caprio will be participating in the debut of The Livingston Healthcare & Life Science Stakeholders Summit - "Capturing Trends and Global Outlook: Advanced and Nano Technologies,
” being held on September 10, 2008 at the Renaissance Hotel Times Square in New York City.
"Over the past three years, the Axiom Capital Management/Livingston Nanotechnology Conference has emerged as an important gathering for the investment community and pioneers in the area of nanotechnology,” said Vincent Caprio, Vice President and Event Director, NanoBusiness Alliance. “I’m excited to be presenting at Scott Livingston’s new event, with a focus on the tremendous opportunities for nanotechnology in the field of healthcare and life science.”
The summit is a unique and by invitation-only conference designed around three important global issues for investors:
- Drug Discovery and Development: Early to Mid-Stage
- Diagnostics: Valuation and Future Directions
- Global and Emerging Investment Opportunities
Invitees include CEOs, CFOs, COOs for a broad range of pharmaceutical, diagnostic, and platform technology companies, a select number of US and International VCs and PEs, along with key policy makers and federal science and regulatory agencies.
“Our Healthcare & Life Sciences Summit has been designed to bring together key stakeholders from pharmaceutical, capital investment, business strategy and federal science and regulatory segments,” said Scott Livingston, managing director of Axiom Capital Management, and head of the Livingston Group, a division within Axiom that focuses on nanotechnology. “Due to its exclusive nature, we can assure that in addition to helping attendees identify key trends, the event will provide for significant opportunities among participants for deal making.”
For information on registering for the Livingston Healthcare & Life Sciences Summit, please contact Jonathan Mason at jmason@axiomcapital.com.
About The NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in Chicago, New York, Connecticut and Washington, DC. For more information, visit http://www.nanobusiness.org.
About Axiom Capital Management Inc. and the Livingston Group
Axiom Capital Management Inc. is a FINRA registered broker/dealer that works with growth companies and institutional investors and provides corporate finance, prime brokerage and private equity opportunities to a wide range of customers.
The Livingston Group was formed by Scott Livingston, who joined Axiom Capital Management Inc. in 2005 after a 15-year career on Wall Street, and has been working exclusively on nanotechnology investments since 2002. Scott has been called "sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at MIT, the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, Albany Nanotech, the Delaware Technology Park, the Business Executives for National Security, Hillary Clinton's Jobs for New York, WXXA Fox 23, Cold Spring Harbor's Dolan DNA Learning Center and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the annual Axiom Capital Management "Livingston Nanotechnology Conference," one of the best attended nanotechnology forums of the year.
Schwartz Public Relations
Steven Wright-Mark
212-677-8700 ext. 29
steven@schwartzpr.com
